Early changes of left ventricular filling pattern after reperfused ST-elevation myocardial infarction and doxycycline therapy: Insights from the TIPTOP trial

Abstract Aim Metalloproteinases inhibition by doxycycline reduces cardiac protein degradation at extracellular and intracellular level in the experimental model ischemia/reperfusion injury. Since both extracellular cardiac matrix and titin filaments inside the cardiomyocyte are responsible for the m...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of cardiology Vol. 240; pp. 43 - 48
Main Authors Cerisano, Giampaolo, Buonamici, Piergiovanni, Parodi, Guido, Santini, Alberto, Moschi, Guia, Valenti, Renato, Migliorini, Angela, Colonna, Paolo, Bellandi, Benedetta, Gori, Anna Maria, Antoniucci, David
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.08.2017
Subjects
E
DT
HFP
NFP
Vp
ECM
PCI
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Aim Metalloproteinases inhibition by doxycycline reduces cardiac protein degradation at extracellular and intracellular level in the experimental model ischemia/reperfusion injury. Since both extracellular cardiac matrix and titin filaments inside the cardiomyocyte are responsible for the myocardial stiffness, we hypothesized that doxycycline could favorably act on left ventricular (LV) filling pressures in patients after reperfused acute ST-elevation myocardial infarction (STEMI). Methods and results Seventy-three of 110 patients of the TIPTOP trial underwent a 2D–Echo-Doppler on admission, and at pre-discharge and at 6-month after a primary PCI for STEMI and LV dysfunction. From admission to pre-discharge, LV filling changed from a high filling pressure (HFP) to a normal filling pressure (NFP) pattern in 91% of the doxycycline-group, and in 67% of the control-group. Conversely, 1% of the doxycycline-group, and 37% of the control-group changed the LV filling from NFP to HFP pattern. Overall, a pre-discharge HFP pattern was present in 4 patients (11%) of the doxycycline-group and in 13 patients (36%) of the control-group (p = 0.025). The evaluation of metalloproteinases and their tissue inhibitors plasma concentrations provide possible favorable action of doxycycline. On the multivariate analyses, troponine I peak (p = 0.026), doxycycline (p = 0.033), and on admission to pre-discharge LVEF changes (p = 0.044) were found to be associated with pre-discharge HFP pattern. Independently of their baseline LV filling behavior, the 6-month remodeling was less in patients with pre-discharge NFP pattern than in patients with HFP pattern. Conclusions In patients with STEMI and LV dysfunction doxycycline can favorably modulate the LV filling pattern early after primary PCI.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-News-3
content type line 23
ISSN:0167-5273
1874-1754
DOI:10.1016/j.ijcard.2017.03.125